Nanopublications

Matches in Nanopublications for { ?s ?p "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 32 of 32 with 100 items per page.

NP252599.RAc_vgYMy-6VZvPP76L4ZvHu4438j-0AUtNcMrE5ZtzSQ130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252599.RAc_vgYMy-6VZvPP76L4ZvHu4438j-0AUtNcMrE5ZtzSQ130_provenance.
NP338583.RARfVIv8YPidaOyriMr9OzQCe24zTw36b16pAZdLCzY3c130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338583.RARfVIv8YPidaOyriMr9OzQCe24zTw36b16pAZdLCzY3c130_provenance.
NP833744.RAaQaQSdn9T5zw5Yevh_h6_ATAFrJ4-f2FCCC1Ofqz6vw130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833744.RAaQaQSdn9T5zw5Yevh_h6_ATAFrJ4-f2FCCC1Ofqz6vw130_provenance.
NP833747.RAVDkVeEf7Dr2KA49OvnPHGULvigneB7ZHMhugwcGzK-E130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833747.RAVDkVeEf7Dr2KA49OvnPHGULvigneB7ZHMhugwcGzK-E130_provenance.
NP838420.RASpm_7ljjJeLTLZMWWeLR6Wcp74e8vGEJgRKUiQEOPZk130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838420.RASpm_7ljjJeLTLZMWWeLR6Wcp74e8vGEJgRKUiQEOPZk130_provenance.
NP710177.RAdeGotF8DS5B5SotDgZq5UsSyCj9vKbf6Y2iLl7TyY1E130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710177.RAdeGotF8DS5B5SotDgZq5UsSyCj9vKbf6Y2iLl7TyY1E130_provenance.
NP710182.RATC17Ll1rkr-O2huzoUESwaPFkZbSMHUlTGqQlbZD-tM130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710182.RATC17Ll1rkr-O2huzoUESwaPFkZbSMHUlTGqQlbZD-tM130_provenance.
NP282998.RACCu5yhm6Zlf25HhdNbA0IfKReEAfMRAKYMVqjQSks6M130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282998.RACCu5yhm6Zlf25HhdNbA0IfKReEAfMRAKYMVqjQSks6M130_provenance.
NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095084.RAa4xnxPt0-4B8gbMD0SgO-qLc6dhCFLXr8BT2NLNwgbM130_provenance.
NP1095089.RAaJ7gLOT8cP61sKj8UUTYdbwfNcrfxdeSelV-LR369EI130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095089.RAaJ7gLOT8cP61sKj8UUTYdbwfNcrfxdeSelV-LR369EI130_provenance.
NP1095091.RAXAOOsj62n4Zz_YZsBHyEp5uo1WGeDJqq3VvSw1KFz0c130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095091.RAXAOOsj62n4Zz_YZsBHyEp5uo1WGeDJqq3VvSw1KFz0c130_provenance.
NP1005058.RAC_rIRq6DrdHvDZwOtuEpfOtT8AhivZAs0uM6RS-wJaY130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005058.RAC_rIRq6DrdHvDZwOtuEpfOtT8AhivZAs0uM6RS-wJaY130_provenance.
NP1095085.RABeS0855Pv94MZ985-pXdsGchAKHVWfMxzfuau-zPTpU130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095085.RABeS0855Pv94MZ985-pXdsGchAKHVWfMxzfuau-zPTpU130_provenance.
NP1095088.RAC4ry-pzMD13WwFkE8jYH4JGCNmgUgeDhbOnH_GfvbS0130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095088.RAC4ry-pzMD13WwFkE8jYH4JGCNmgUgeDhbOnH_GfvbS0130_provenance.
NP1095096.RACFYsJd_Oml1BNbv0jTYfeh4-Hh_R8UjUYgWB-lS5u5w130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095096.RACFYsJd_Oml1BNbv0jTYfeh4-Hh_R8UjUYgWB-lS5u5w130_provenance.
NP338593.RAuwc6YbYWVN7IcQb_S2Wyre5bAf3Mkhi3AWH5mgLwfqw130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338593.RAuwc6YbYWVN7IcQb_S2Wyre5bAf3Mkhi3AWH5mgLwfqw130_provenance.
NP1005055.RAtbtvdHLLcwgJKyJEoyayEcZfOEmFOiP-yESAUetERJM130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005055.RAtbtvdHLLcwgJKyJEoyayEcZfOEmFOiP-yESAUetERJM130_provenance.
NP1095087.RAoTbJPyq7FuqXq6mjISYsOCYoHT5Nky35xPWR8DKON2Y130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095087.RAoTbJPyq7FuqXq6mjISYsOCYoHT5Nky35xPWR8DKON2Y130_provenance.
NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095092.RAiXMS4DAk4G_V2rHlvQZ5B07uG1Qli28ErwXvcWWX6qk130_provenance.
NP1095095.RArnMkPPxREbEGVeFapa9jQ7YKgqdzwgqxBEuGzKq72fM130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095095.RArnMkPPxREbEGVeFapa9jQ7YKgqdzwgqxBEuGzKq72fM130_provenance.
NP1095097.RAmRwmLELEO3mvY3_D1IvCjg-CzDMOiHZlRvQrGGfNYVo130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095097.RAmRwmLELEO3mvY3_D1IvCjg-CzDMOiHZlRvQrGGfNYVo130_provenance.
NP1095098.RAnLqpKkffx9t9_4NEYxdNFMb3kF0g-55xH75VHgJGD6s130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095098.RAnLqpKkffx9t9_4NEYxdNFMb3kF0g-55xH75VHgJGD6s130_provenance.
NP283032.RA3k0pE8tdGqDbLUUoIUFJLT8p5XvaOZOwGe87U8Dtxvg130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283032.RA3k0pE8tdGqDbLUUoIUFJLT8p5XvaOZOwGe87U8Dtxvg130_provenance.
NP252595.RA0yIxUFhVvfpSMnqgO0QFIqlFY-DamjYbx99UkCfMfZQ130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252595.RA0yIxUFhVvfpSMnqgO0QFIqlFY-DamjYbx99UkCfMfZQ130_provenance.
NP642329.RA1bwYGOWW532OdcxEE7ntTLZVsr7dBsSZQaPSJI-XtpQ130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642329.RA1bwYGOWW532OdcxEE7ntTLZVsr7dBsSZQaPSJI-XtpQ130_provenance.
NP642360.RA7NlZgtJevZMSmQY98YpF1owJHPlNvEAPWGaHf0ouq1k130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642360.RA7NlZgtJevZMSmQY98YpF1owJHPlNvEAPWGaHf0ouq1k130_provenance.
NP1095090.RAFwgl_Bc7SYtujlb_x84qCMyntrOVbDecWQysbM87fJA130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095090.RAFwgl_Bc7SYtujlb_x84qCMyntrOVbDecWQysbM87fJA130_provenance.
NP1095093.RANxruQcDF2NP3B30uIHthEMTmSzrORiZs8izVAkainLM130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095093.RANxruQcDF2NP3B30uIHthEMTmSzrORiZs8izVAkainLM130_provenance.
NP1095094.RAKzrLIsDtOGP8NjAZ7aqLjVDPDBIccGCmmq445UzqBuI130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095094.RAKzrLIsDtOGP8NjAZ7aqLjVDPDBIccGCmmq445UzqBuI130_provenance.
NP1095083.RAy6k7Ll7J5LB2nhLzKyt2BPgd1PCW7UIFz-He1IxbW9o130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095083.RAy6k7Ll7J5LB2nhLzKyt2BPgd1PCW7UIFz-He1IxbW9o130_provenance.
NP1095086.RAymKf86ZbUwlnOpldQOejZapREpkg9KM4R1F_yoQ4puY130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095086.RAymKf86ZbUwlnOpldQOejZapREpkg9KM4R1F_yoQ4puY130_provenance.
NP838417.RA5cnojjTzfsD5ZkkY7C1-xHbfvWmwyZwiSxr9idCz0b0130_assertion description "[We evaluated Ad.5/3-CTV in comparison with Ad.5-CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838417.RA5cnojjTzfsD5ZkkY7C1-xHbfvWmwyZwiSxr9idCz0b0130_provenance.